XML 24 R13.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 8 - Shareholders' Equity
9 Months Ended
Sep. 25, 2016
Notes to Financial Statements  
Shareholders' Equity and Share-based Payments [Text Block]
8.
SHAREHOLDERS’ EQUITY
 
We recorded non-cash stock compensation expense in each period as follows:
 
 
 
Three-Month Periods E
nded
 
 
Nine-Month Periods E
nded
 
 
 
Sept.
2
5
,
 
 
Sept. 27
,
 
 
Sept.
2
5
,
 
 
Sept.
2
7
,
 
 
 
2016
 
 
2015
 
 
2016
 
 
2015
 
Stock Options
  $ 197     $ 112     $ 525     $ 368  
Restricted Stock Grants
    8       23       30       71  
Total
  $ 205     $ 135     $ 555     $ 439  
 
These are more fully discussed as follows:
 
a. Stock Options
 
We have stock options outstanding from various stock-based employee compensation plans for which we record compensation cost relating to share-based payment transactions in our financial statements. As of September 25, 2016, there was $666 of total unrecognized compensation cost related to outstanding stock options, which is expected to be recognized over a weighted average period of 1.25 years.
 
The following table summarizes stock option activity for the nine-month period ended September 25, 2016:
 
 
 
Number of
Shares
 
 
Weighted
Average
Exercise
Price
 
 
Weighted
Average
Remaining
Contractual
Term (years)
 
 
Aggregate
Intrinsic
Value
 
Outstanding at January 1, 2016
    2,257,969     $ 6.30                  
Granted
    346,000       4.71                  
Exercised
    (47,642 )     3.81                  
Forfeited or Expired
    (64,651 )     8.02                  
Outstanding at Sept. 25, 2016
    2,491,676       6.08       3.46     $ 246  
Vested and Expected to Vest at
Sept. 25, 2016
    2,347,190       6.17       3.26     $ 226  
Exercisable at Sept. 25, 2016
    1,392,204     $ 4.90       2.17     $ 168  
 
 
The following assumptions were used to value stock options granted during the nine months ended September 25, 2016:
 
Risk-Free Interest Rate
    0.89 %
Volatility Factor
    48.08 %
Dividends
    0.00 %
Weighted Average Expected Life (Years)
    2.82  
 
The weighted average grant date fair value of options granted during the nine months ended September 25, 2016 was $2.01.
 
FASB’s guidance for share-based payments requires cash flows from excess tax benefits to be classified as a part of cash flows from financing activities. Excess tax benefits are realized tax benefits from tax deductions for exercised stock options in excess of the deferred tax asset attributable to stock compensation costs for such stock options. We did not record any excess tax benefits in the first nine months of 2016 or 2015.
 
Cash received from stock option exercises under our stock-based compensation plans for the three-month periods ended September 25, 2016 and September 27, 2015 was $106 and $19, respectively. Cash received from stock option exercises for the nine-month periods ended September 25, 2016 and September 27, 2015 was $181 and $28, respectively.
 
 
 
b. Restricted Stock Awards
 
In September 2014, 49,200 shares of restricted stock were awarded to certain of our employees. These units vest over three years and we estimated their weighted average grant date fair value to be $3.24 per share. In September 2016, 15,900 shares of the awarded restricted stock vested and the Company repurchased 4,131 shares to satisfy the statutory tax withholding on shares vested for certain employees. There is $15 of unrecognized compensation cost related to these restricted shares at September 25, 2016.